Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX: MCRO)
Egypt
· Delayed Price · Currency is EGP 2.530
-0.070 (-2.69%)
At close: Dec 19, 2024
EGX: MCRO Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -436.86 | -272.65 | 173.84 | 147.93 | 135.13 |
| Depreciation & Amortization | 18.73 | 16.72 | 13.62 | 6.6 | 1.94 |
| Other Amortization | 0.8 | 0.51 | 0.68 | - | - |
| Loss (Gain) From Sale of Assets | 0.02 | 0.02 | - | - | - |
| Asset Writedown & Restructuring Costs | 24.42 | 24.42 | - | - | - |
| Provision & Write-off of Bad Debts | 125.28 | 98.43 | 3.15 | 0.5 | 3.06 |
| Other Operating Activities | 77.71 | 47.87 | 20.5 | 20.47 | 7.22 |
| Change in Accounts Receivable | 228.07 | 104.94 | -33.58 | -131.35 | -87.12 |
| Change in Inventory | -1.35 | -67.65 | -73.12 | -19.33 | -12.55 |
| Change in Accounts Payable | -15.44 | 20.25 | 27.74 | 16.69 | 1.29 |
| Change in Other Net Operating Assets | 19.19 | -10.87 | 2.1 | 8.74 | -3.02 |
| Operating Cash Flow | 37.26 | -38.01 | 134.93 | 50.26 | 45.94 |
| Operating Cash Flow Growth | 872.35% | - | 168.48% | 9.39% | - |
| Capital Expenditures | -7.09 | -6.44 | -5.3 | -5.81 | -7.06 |
| Sale of Property, Plant & Equipment | -1.42 | 0.04 | - | - | - |
| Cash Acquisitions | - | - | - | -1.5 | - |
| Sale (Purchase) of Intangibles | - | - | -3.5 | - | - |
| Investment in Securities | 3.29 | - | - | - | -2.53 |
| Other Investing Activities | 5.92 | 1.98 | 2.8 | 1.5 | 12.56 |
| Investing Cash Flow | 0.7 | -4.42 | -6.01 | -5.82 | 2.97 |
| Short-Term Debt Issued | - | 293.77 | 286.33 | 7.25 | 48.09 |
| Total Debt Issued | 408.06 | 293.77 | 286.33 | 7.25 | 48.09 |
| Short-Term Debt Repaid | - | -260.57 | -212.08 | - | - |
| Long-Term Debt Repaid | - | -12.25 | -11.88 | -4.58 | - |
| Total Debt Repaid | -319.23 | -272.82 | -223.96 | -4.58 | - |
| Net Debt Issued (Repaid) | 88.83 | 20.95 | 62.37 | 2.67 | 48.09 |
| Repurchase of Common Stock | - | -29.97 | -24.87 | - | - |
| Common Dividends Paid | -54 | -60 | -40 | -46.82 | -73.85 |
| Financing Cash Flow | 56.65 | -69.02 | -2.5 | -44.15 | -25.76 |
| Net Cash Flow | 94.61 | -111.44 | 126.43 | 0.29 | 23.15 |
| Free Cash Flow | 30.17 | -44.44 | 129.63 | 44.44 | 38.88 |
| Free Cash Flow Growth | - | - | 191.67% | 14.31% | - |
| Free Cash Flow Margin | 11.80% | -8.45% | 17.77% | 7.48% | 9.03% |
| Free Cash Flow Per Share | 0.05 | -0.08 | 0.23 | 0.08 | 0.07 |
| Cash Interest Paid | 36.44 | 25.27 | 10.14 | 6.26 | 3.16 |
| Cash Income Tax Paid | - | 48.79 | 45.71 | 42.95 | 37.93 |
| Levered Free Cash Flow | 116.39 | 84.42 | 75.76 | -1 | - |
| Unlevered Free Cash Flow | 145.55 | 102.85 | 84.18 | 4.1 | - |
| Change in Net Working Capital | -372.51 | -206.04 | 67.79 | 123.95 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.